Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v13-EN
Language French English
Date Updated 2019-02-19 2019-02-19
Drug Identification Number 02355981 02355981
Brand name ASCOR L 500 ASCOR L 500
Common or Proper name Ascorbic Acid Injection, USP Ascorbic Acid Injection, USP
Company Name MCGUFF PHARMACEUTICALS INC MCGUFF PHARMACEUTICALS INC
Ingredients VITAMIN C VITAMIN C
Strength(s) 500MG 500MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 50 mL 50 mL
ATC code A11GA A11GA
ATC description ASCORBIC ACID (VIT C), INCL COMBINATIONS ASCORBIC ACID (VIT C), INCL COMBINATIONS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-01-03 2018-01-03
Estimated end date 2019-05-31 2019-05-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments shortage caused by supply/demand constraints due to new approval in United States shortage caused by supply/demand constraints due to new approval in United States
Health Canada comments